1. Home
  2. FFBC vs MLYS Comparison

FFBC vs MLYS Comparison

Compare FFBC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

N/A

Current Price

$29.77

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$24.75

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FFBC
MLYS
Founded
1863
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
FFBC
MLYS
Price
$29.77
$24.75
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$30.71
$48.67
AVG Volume (30 Days)
735.3K
1.4M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.34%
N/A
EPS Growth
10.83
37.43
EPS
0.71
N/A
Revenue
N/A
N/A
Revenue This Year
$27.67
N/A
Revenue Next Year
$4.58
N/A
P/E Ratio
$41.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.94
$12.59
52 Week High
$31.38
$47.65

Technical Indicators

Market Signals
Indicator
FFBC
MLYS
Relative Strength Index (RSI) 51.51 37.41
Support Level $29.10 $22.42
Resistance Level $31.24 $31.12
Average True Range (ATR) 0.56 1.61
MACD -0.09 -0.42
Stochastic Oscillator 44.54 18.25

Price Performance

Historical Comparison
FFBC
MLYS

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: